Today, President Trump signed two bills into law that will allow pharmacists to disclose the lowest cost of prescriptions to their patients.

Previously, pharmacy benefit managers (PBMs) have enforced so-called “gag clauses” that prohibited pharmacists from informing their patients if they could purchase their prescriptions for a lower cost out-of-pocket vs. through insurance.

The Patient Right to Know Drug Prices Act and the Know the Lowest Price Act prevent gag clauses on both Medicare Part D and private insurance plans.

Currus, alongside NCPA and other organizations, are excited about the signing of this legislation and its potential impact on consumer costs. It’s a step in the right direction towards better drug-pricing transparency for pharmacists and most importantly – their patients.